MarketPulse

stock price decline

514 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

uniQure Stock Crashes 49% on FDA Setback; Class Action Deadline Looms

uniQure faces securities lawsuit after FDA rejected AMT-130 approval pathway. Stock plummeted 49% following disclosure. Lead plaintiff deadline: April 13, 2026.
QUREsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

Kyndryl Faces Major Securities Lawsuit After 55% Stock Collapse on Control Failures

Kyndryl Holdings faces securities class action over undisclosed internal control weaknesses. Stock plunged 55% after February 2026 disclosure; lead plaintiff deadline set for April 13.
KDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

$CORT Plummets 50% After FDA Rejection; Class Action Deadline Looms for Major Shareholders

$CORT stock plummets 50% after FDA rejects lead drug relacorilant; class action targets alleged disclosure failures with lead plaintiff deadline April 21, 2026.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

BellRing Brands Faces Securities Class Action Over Material Disclosure Failures

BellRing Brands faces securities class action alleging material disclosure failures from November 2024–August 2025, with stock declines of 19% and 33% following disappointing guidance.
BRBRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

PayPal Faces Securities Lawsuit Over Missed Guidance as Stock Plunges 20%

Securities class action filed against PayPal for allegedly misleading investors on revenue outlook. Stock fell over 20% after disappointing February 2026 earnings and unachievable 2027 targets.
PYPLsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Nektar Therapeutics Faces Securities Class Action Over Failed Trial Disclosure

Nektar Therapeutics faces securities class action over alleged misstatements about REZOLVE-AA trial, with stock falling 7.77% after trial failure announcement.
NKTRclass actionstock price decline
BenzingaBenzinga··Business Wire

Driven Brands Faces Securities Fraud Lawsuit After 30% Stock Plunge on Accounting Errors

Driven Brands faces securities fraud class action after disclosing accounting errors spanning 2023-2026, triggering a 30.2% stock collapse. Shareholders can file lead plaintiff motions by May 8, 2026.
DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Corcept Stock Plummets 50% After FDA Rejects Key Drug; Lawsuit Probe Launched

Johnson Fistel investigates Corcept Therapeutics ($COPT) for securities violations after FDA rejected relacorilant application, triggering 50% stock decline.
CORTinvestor lossesrelacorilant
The Motley FoolThe Motley Fool··Robert Izquierdo

Wingstop Director Dumps $704K in Stock as Sales Slip, Valuation Concerns Mount

Wingstop director sold 2,700 shares worth $704K amid 6% same-store sales decline and 10% stock drop in 2026, raising valuation concerns.
WINGvaluationstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Gossamer Bio Stock Crashes 80% After Failed Drug Trial, Triggering Securities Probe

Pomerantz LLP investigates Gossamer Bio after seralutinib Phase 3 trial failure triggers 80% stock crash, raising securities fraud concerns.
ALITCCGOSSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

EPAM Systems Faces Securities Fraud Investigation After Major Customer Pullback

Pomerantz Law Firm investigates EPAM Systems for potential securities fraud after disclosure that largest customer NEORIS is reducing business, triggering 6.61% stock decline.
ALITCCEPAMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Stellantis Faces Securities Probe After €22.2B Charge Triggers Sharp Stock Plunge

Law firm investigates Stellantis after €22.2 billion charge announcement causes 23.69% stock drop. Class action lawsuit being formed for affected investors.
STLAALITCCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Snowflake Faces Class Action Lawsuit Over $SNOW Stock Plunge Following Revenue Guidance Miss

Pomerantz Law Firm filed securities fraud lawsuit against Snowflake after February 2024 revenue warning triggered 18% stock decline. Investors can join until April 2026.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Navan Faces Class Action Over IPO Disclosure Gaps as Pomerantz Targets Securities Violations

Pomerantz Law Firm filed class action lawsuit against Navan, alleging the company concealed 39% surge in sales/marketing expenses around October 2025 IPO.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Mereo BioPharma Stock Collapsed 87.7% After Trial Failure; Class Action Deadline Looms

Pomerantz Law Firm filed class action against $MREO after Phase 3 trial failures. Stock plummeted 87.7%. Investor deadline: April 6, 2026.
NAVNSNOWMREOsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Robert Izquierdo

Freshworks Insider Sell-Off Masks Bullish Fundamentals as Stock Eyes Recovery

Freshworks executive sells $275K in shares via pre-planned trading program, but analyst maintains buy rating citing 16% revenue growth and improving profitability.
FRSHvaluationstock price decline
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

PRCT Stock Plunges 15% After Revenue Miss Triggers Securities Fraud Investigation

PROCEPT BioRobotics faces securities fraud investigation after missing earnings and cutting 2026 guidance by $20-30 million, triggering a 15% stock plunge.
PRCTshareholder lawsuitstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Pinterest Faces Securities Fraud Investigation After Steep Stock Plunge

Portnoy Law Firm investigates Pinterest for potential securities fraud following 16.83% stock decline after disappointing Q4 2025 results.
PINSsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PennyMac Stock Plunges 33% After Q4 Results Disappoint; Class Action Probe Launched

PennyMac Financial Services stock crashed 33.3% following weak Q4 2025 earnings, prompting securities investigation into alleged misleading disclosures.
PFSIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

GSI Technology Stock Plunges 14.2% Amid Securities Fraud Probe Over AI Claims

The Rosen Law Firm investigates alleged securities fraud at GSI Technology ($GSIT) following a 14.2% stock decline tied to misrepresented AI chip capabilities.
SANBCSGSITsecurities fraudclass action lawsuit